Vaishali Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Vaishali Pharma has a total shareholder equity of ₹677.6M and total debt of ₹123.5M, which brings its debt-to-equity ratio to 18.2%. Its total assets and total liabilities are ₹1.0B and ₹361.9M respectively. Vaishali Pharma's EBIT is ₹14.4M making its interest coverage ratio 2. It has cash and short-term investments of ₹11.4M.
Key information
18.2%
Debt to equity ratio
₹123.46m
Debt
| Interest coverage ratio | 2x |
| Cash | ₹11.43m |
| Equity | ₹677.63m |
| Total liabilities | ₹361.85m |
| Total assets | ₹1.04b |
Recent financial health updates
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11
Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19
Recent updates
Investors Give Vaishali Pharma Limited (NSE:VAISHALI) Shares A 33% Hiding
Nov 15A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb
Sep 13The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More
Jul 05Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23Financial Position Analysis
Short Term Liabilities: VAISHALI's short term assets (₹983.9M) exceed its short term liabilities (₹329.7M).
Long Term Liabilities: VAISHALI's short term assets (₹983.9M) exceed its long term liabilities (₹32.2M).
Debt to Equity History and Analysis
Debt Level: VAISHALI's net debt to equity ratio (16.5%) is considered satisfactory.
Reducing Debt: VAISHALI's debt to equity ratio has reduced from 71.9% to 18.2% over the past 5 years.
Debt Coverage: VAISHALI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: VAISHALI's interest payments on its debt are not well covered by EBIT (2x coverage).